Intercept to Present at Upcoming Investor Conferences in May
Bank of America Merrill Lynch Health Care Conferencein Las Vegas, NVat 11:20 a.m. PTon Tuesday, May 14, 2019 UBS Global Healthcare Conferencein New York, NYat 1:00 p.m. ETon Tuesday, May 21, 2019 RBC Capital Markets Global Healthcare Conferencein New York, NYat 11:30 a.m. ETon Wednesday, May 22, 2019
Webcast information for these events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept’s website for approximately two weeks.
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in
For more information about Intercept, please contact:
Media inquiries: firstname.lastname@example.org
Source: Intercept Pharmaceuticals, Inc.